67 results
Page 2 of 4
6-K/A
EX-99.2
z72obu5p9j1jjrm
13 Oct 21
ObsEva Announces Relationship with Syneos Health to Commercialize Linzagolix
5:24pm
6-K/A
EX-99.5
q9eox8 az
13 Oct 21
ObsEva Announces Relationship with Syneos Health to Commercialize Linzagolix
5:24pm
6-K
EX-99.2
zwt2dstbqldbly6noc
13 Oct 21
ObsEva Announces Relationship with Syneos Health to Commercialize Linzagolix
9:27am
6-K
EX-99.5
5729gwbg1
13 Oct 21
ObsEva Announces Relationship with Syneos Health to Commercialize Linzagolix
9:27am
6-K
EX-99.1
0611 ebajkcc3m
22 Apr 21
ObsEva Annual General Meeting 2021
6:31am
6-K
EX-4.2
x7xbs ja5djgmxcvwa4
8 Sep 20
ObsEva Announces $20.0 Million Underwritten Offering and Concurrent Private Placement
7:40am
6-K
EX-1.1
8uyx 1edn5r
8 Sep 20
ObsEva Announces $20.0 Million Underwritten Offering and Concurrent Private Placement
7:40am
6-K
EX-4.1
wnhxo767
8 Sep 20
ObsEva Announces $20.0 Million Underwritten Offering and Concurrent Private Placement
7:40am
UPLOAD
j76c 05zsrkhj4vr6l
8 Aug 19
Letter from SEC
12:00am
F-3
EX-4.6
ea9z7jjgbxv 7gj0
7 Aug 19
Shelf registration (foreign)
8:24am
F-3
EX-4.2
n6dkg3mk
7 Aug 19
Shelf registration (foreign)
8:24am